Tamoxifen for breast cancer among hysterectomised women
- 1 March 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 359 (9312) , 1122-1124
- https://doi.org/10.1016/s0140-6736(02)08159-x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Risk and prognosis of endometrial cancer after tamoxifen for breast cancerThe Lancet, 2000
- Drop-outs in tamoxifen prevention trialsThe Lancet, 1999
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised womenThe Lancet, 1998